- First product launch
MarBiLeads launches its first product ready for licensing.
- Company R&D
MarBiLeads has in close collaboration with its strategic partners since 2011 carried out the R&D project "New antimicrobial and anticancer leads from the marine bacterial library".
- Bioprospecting Conference
MarBiLeads presented a poster at The 7ᵗʰ International Conference on Marine Bioprospecting in Tromsø.
View updated poster
Novel Drugs from the Sea
MarBiLeads AS is a biotechnology company specialising in the identification and characterization of new bioactive compounds produced by marine microorganisms isolated from bioprospecting of Norwegian sea waters.
The company develops new drug leads for the treatment of difficult- to-treat infections due to multi- drug-resistant bacteria, and for the treatment of cancer.
MarBiLeads AS sells and markets its patented drug leads to major players in the international pharma market.
Business for you:
MarBiLeads offers exclusive worldwide licenses to its portfolio of patented drug leads.
MarBiLeads seeks well qualified agents with documented networks for sale of licenses on a shared profit basis worldwide.
MarBiLeads invites new investors to join and participate in the further development of the company.